Showing 1 to 10 of 33 Clinical Trials
|
CLINICAL TRIAL Trial No ClinicalTrials.gov ID |
Principal Investigator
Coordinator |
||
|---|---|---|---|
|
An Open-label, Multi-center, Phase I Study of Oral IAG933 in Adult Patients With Advanced Mesothelioma and Other Solid Tumors
CIAG933A12101 NCT04857372  Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
Mesothelioma Solid Tumors |
Dr. Marie Florescu Adeline Hamon 514-890-8000 poste 30737 |
|
Phase I Trial of PCLX-001 in Relapsed/Refractory B-cell Non-Hodgkin Lymphoma and Advanced Solid Malignancies
PCLX-001-01 NCT04836195 Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
Non-Hodgkin's Lymphoma Solid Tumors |
Dr. Rahima Jamal Adeline Hamon 514-890-8000 poste 30737 |
|
Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR): A Phase II Basket Trial
CAPTUR/PM.1 NCT03297606 Recruiting
|
CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL
HOPITAL GENERAL JUIF SIR MORTIMER B.DAVIS
|
Solid Tumors |
Dr. Cristiano Ferrario Inna Zhylina 514-340-8222 poste 28437 |
|
A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors
GARNET NCT02715284 Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
Solid Tumors |
Dr. Vanessa Samouëlian Shirley Truchon 514-890-8000 poste 25350 |
|
A Phase 1 Study of [225Ac]-FPI-1434 Injection in Patients With Advanced Solid Tumours
FPX-01-01 NCT03746431 Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
Solid Tumors |
Dr. Fred Saad Amal Nadiri 514-890-8000 poste 26074 |
|
A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors
GARNET NCT02715284 Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
SITE GLEN
|
Solid Tumors |
Dr. Lucy Gilbert Phuong-Nam (Nathalie) Nguyen 514-934-1934 poste 31975 |
|
A Phase II, Multicentre, Open-label, Master Protocol to Evaluate the Efficacy and Safety of Datopotamab Deruxtecan (Dato-DXd) as Monotherapy and in Combination With Anticancer Agents in Patients With Advanced/Metastatic Solid Tumours
TROPION-PanTumor03 NCT05489211 Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
SITE GLEN
|
Solid Tumors |
Dr. Ramy Saleh Rodrigo Skowronski 514-934-1934 poste 36275 |
|
A phase 1A/B open-label master study of PF-07799544 as a single-agent and in combination with other targeted agents in participants with advanced solid tumors
C4901001 NCT05538130 Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
SITE GLEN
|
Solid Tumors |
Dr. Ramy Saleh Abdul-Rahman El-Hassan 514-934-1934 poste 35161 |
|
A Multicenter, Open Label, Phase III Extension Trial to Study the Long-term Safety and Efficacy in Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab Trial
MK-3475-587 NCT03486873 Recruiting
|
CHU DE QUEBEC – UNIVERSITE LAVAL
L'HOTEL-DIEU DE QUEBEC ET CRCEO
|
Solid Tumors |
Dr. Yves Fradet Marilyn Savard 418-525-4444 poste 20414 |
|
Prospective Non-interventional Study in Patients With Locally Advanced or Metastatic TRK Fusion Cancer Treated With Larotrectinib
20324 NCT04142437 Recruiting
|
CHU DE QUEBEC – UNIVERSITE LAVAL
CHUL ET CENTRE MERE-ENFANT SOLEIL
|
Solid Tumors |
Dr. Valérie Larouche Panagiota Giannakouros 418-525-4444 poste 40121 |
Groupe d'étude en oncologie du Québec